Securities fraud litigation history and active cases
Active Cases
0
Pending Settlement
1
Closed
0
Total Settlement
$11.5M
Vanda Pharmaceuticals Inc. (VNDA) Class Action Lawsuit (February 2019)Pending Settlement
1:19cv1108 • February 25, 2019
Class Period Start
November 3, 2015
Class Period End
May 10, 2019
PSLRA Deadline
April 26, 2019
Case Allegations
10b5
Statutes of Repose
Nov 3, 2018
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 28, 2022
Settlement Fund
$11,500,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that O PURCHASED OR ACQUIRED THE COMMON STOCK OF VANDA PHARMACEUTICALS, INC. (“VANDA” OR THE “COMPANY”) DURING THE PERIOD FROM NOVEMBER 4, 2015 TO FEBRUARY 11, 2019, INCLUSIVE.
Claim Administrator
Epiq
Vanda Securities Litigation
Claims Administrator
P.O. Box 4419
Portland, OR 97208-4419
+1 866-329-5443
[email protected]
Settlement Website
www.vandasecuritieslitigation.comHearing Date
January 5, 2023
Opt-out Deadline
December 15, 2022
Settlement Note
Download hereProof Of Claim
Download here
Docket History
Jan 11, 2023
Final Approval of Settlement
Sep 15, 2022
Sep 15, 2022
Preliminary Approval of Settlement
Sep 15, 2022
Proof of Claim Form
May 19, 2022
Proposed Settlement
Jan 28, 2022
Motion for Class Certification
Mar 10, 2021
Motion to Dismiss Denied
Jun 9, 2020
Motion to Dismiss
Oct 8, 2019
Scheduling Order
Sep 12, 2019
Scheduling Order
Jul 23, 2019
First Amended Complaint
May 24, 2019
Appointment of Lead Plaintiff
Feb 25, 2019
First Filed Complaint
TOP
